Search

Your search keyword '"PULMONARY surfactant"' showing total 386 results

Search Constraints

Start Over You searched for: Descriptor "PULMONARY surfactant" Remove constraint Descriptor: "PULMONARY surfactant" Publisher springer nature Remove constraint Publisher: springer nature
386 results on '"PULMONARY surfactant"'

Search Results

1. Assessing vitamin E acetate as a proxy for E-cigarette additives in a realistic pulmonary surfactant model.

2. Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization.

3. Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation.

4. The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits.

5. Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans.

6. Low incidence of acute kidney injury in VLBW infants with restrictive use of mechanical ventilation.

7. Influence of Composition and Temperature on Dynamic Properties of Mixed Monolayers of Pulmonary Lipids.

8. The adhesion GPCR GPR116/ADGRF5 has a dual function in pancreatic islets regulating somatostatin release and islet development.

9. Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery.

10. Xenon-Induced Recovery of Functional Activity of Pulmonary Surfactant (In Silico Study).

11. Uninformed Origins: Should We Be Advising Parents on the Source of Medicines and Therapies?

12. A mammalian lung's immune system minimizes tissue damage by initiating five major sequential phases of defense.

13. Dynamic Properties of Pulmonary Lipid Monolayers on the Surfaces of Sodium Polystyrene Sulfonate and Polydiallyldimethylammonium Chloride Solutions.

14. Spectral-Selective X-Ray Studies at the "Langmuir" Beamline of the Kurchatov Synchrotron Radiation Source.

15. Alveolar macrophage metabolic programming via a C-type lectin receptor protects against lipo-toxicity and cell death.

16. Correction: Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: <italic>In Vitro</italic> Testing and Characterization.

17. Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part II: <italic>In vivo</italic> Efficacy Testing in a Rabbit Surfactant Washout Model.

18. Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis.

19. Reduced levels of pulmonary surfactant in COVID-19 ARDS.

20. Enhanced INSURE (ENSURE): an updated and standardised reference for surfactant administration.

21. Latency duration of preterm premature rupture of membranes and neonatal outcome: a retrospective single-center experience.

22. Mechanisms of the Effects of Short-Term Inhalations of Xe and O2 Gas Mixture in the Rehabilitation of Post-COVID Ventilation Failure.

23. Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo.

24. Trafficking of newly synthesized surfactant protein B to the lamellar body in alveolar type II cells.

25. A new clinical respiratory distress score for surfactant therapy in preterm infants with respiratory distress.

26. Graphene-based sensing of oxygen transport through pulmonary membranes.

27. Lung Surfactant Accelerates Skin Wound Healing: A Translational Study with a Randomized Clinical Phase I Study.

28. Lung ultrasound in preterm infants with respiratory distress: experience in a neonatal intensive care unit.

29. Evaluation of the Efficiency of Lubricant Based on Pulmonary Surfactant in Experimental Knee Osteoarthritis in Rats: Analysis of 3D Reconstructions.

30. SP-D attenuates LPS-induced formation of human neutrophil extracellular traps (NETs), protecting pulmonary surfactant inactivation by NETs.

31. Imaging drugs, metabolites and biomarkers in rodent lung: a DESI MS strategy for the evaluation of drug-induced lipidosis.

33. High-resolution and high-repetition-rate vibrational sum-frequency generation spectroscopy of one- and two-component phosphatidylcholine monolayers.

34. High-resolution computed tomography findings of thyroid transcription factor 1 deficiency (NKX2-1 mutations).

35. Air-blood barrier thickening and alterations of alveolar epithelial type 2 cells in mouse lungs with disrupted hepcidin/ferroportin regulatory system.

36. Clinical characteristic comparison of low birth weight and very low birth weight preterm infants with neonatal necrotizing enterocolitis: a single tertiary center experience from eastern China.

37. Lung ultrasound-guided surfactant administration: time for a personalized, physiology-driven therapy.

38. Surface Dilatational Elasticity of Pulmonary Surfactant Solutions in a Wide Range of Surface Tensions.

39. Pulmonary surfactant-associated proteins and inflammatory factors in obstructive sleep apnea.

40. Gene variants of the phosphatidylcholine synthesis pathway do not contribute to RDS in the Chinese population.

41. Achieving and maintaining lung volume in the preterm infant: from the first breath to the NICU.

42. Poractant alfa in respiratory distress syndrome in preterm infants: a profile of its use.

43. External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome.

44. Effect of Surfactant Therapy Using Orogastric Tube for Tracheal Catheterization in Preterm Newborns with Respiratory Distress.

45. Lung surfactant metabolism: early in life, early in disease and target in cell therapy.

46. The biology of the ABCA3 lipid transporter in lung health and disease.

47. Effects of different surfactant administrations on cerebral autoregulation in preterm infants with respiratory distress syndrome.

48. Current Concepts in the Management of Meconium Aspiration Syndrome.

49. Individualized lung recruitment during high-frequency ventilation in preterm infants is not associated with lung hyperinflation and air leaks.

50. Population-based frequency of surfactant dysfunction mutations in a native Chinese cohort.

Catalog

Books, media, physical & digital resources